- Global Pharma News & Resources

Press Releases - 2021-07-27

Date Title Company
27-Jul-2021 Xihua Scientific Selects LifeSphere MultiVigilance to Advance Pharmacovigilance Services ArisGlobal
27-Jul-2021 3D Cell Culture Market Growth by Products, Applications and Forecast to 2024 MarketsandMarkets
27-Jul-2021 ​​​​​​​Half Year Results Stronger than Expected; Eckert & Ziegler Increases Profit Forecast by approximately 20% Eckert & Ziegler Strahlen- und Medizintechnik AG
27-Jul-2021 Biotium Launches First Ever Mounting Media with Far-Red Nuclear Counterstain and Autofluorescence Quenching Reagent Biotium
27-Jul-2021 Asia-Pacific Bioinformatics Market 2021 Size, Share, Growth Rate of 14.1%, Industry Trends, Leading Players Updates, Industry Demand by Forecast to 2028||DBMR Insights The Wire Times
27-Jul-2021 UK scientists designed the world’s most sophisticated COVID-19 sequencing system – here’s how they did it University of Birmingham,
27-Jul-2021 Telemedicine is here to stay: the pros and cons according to GPs and patients Buzzback
27-Jul-2021 ADVANZ PHARMA announces launch of MYTOLAC® in Germany, the first generic lanreotide for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumours (GEP-NETs) ADVANZ PHARMA
27-Jul-2021 Team Europe pledges support for eradicateMalaria, an initiative aiming to facilitate the development and production of a highly efficacious malaria vaccine BioNTech
27-Jul-2021 EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of the Moderna COVID-19 Vaccine in Adolescents (12-17 Years of Age) in the European Union Moderna, Inc.
27-Jul-2021 4D pharma announces passing of Chief Financial Officer John Beck 4D pharma
27-Jul-2021 F-star Therapeutics Provides Interim Update on SB 11285 First-In-Human Dose-Escalation Study in Patients with Advanced Solid Tumors F-star Therapeutics
27-Jul-2021 EVERSANA™ expands global commercialization solutions with acquisition of Accelera Canada and its partner companies EVERSANA™
27-Jul-2021 Mediclinic International 2021 Annual General Meeting Statement Mediclinic International
27-Jul-2021 Global Artificial Blood Substitutes Market Will Accelerate Rapidly with Excellent CAGR of 25.6% by 2028||Demand,Risks, Opportunities,Covid-19 Impact Analysis By HEMARINA, Hemoglobin Oxygen Therapeutics LLC, KaloCyte, Inc., LLC “Visusmed” The Wire Times
27-Jul-2021 Panthera steps up its move into oncology trials with more than 12 trials in the pipeline and a prostate trial underway Panthera
27-Jul-2021 Olink: CORAL to use the Olink Proteomics platform to identify novel protein biomarkers and biological mechanisms for neurological diseases Olink Holding AB
27-Jul-2021 Autolomous collaboration awarded grant by UK Research and Innovation (UKRI) for GBP 1 million project that will schedule ATMP manufacturing within UK national health provider Autolomous Ltd
27-Jul-2021 ValenzaBio Partners with ProBioGen to Maximize Cell Line Productivity and Licenses GlymaxX® ProBioGen